v3.25.1
Condensed Consolidated Statements of Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Accumulated Deficit
Accumulated  Other Comprehensive Loss, Net of Tax
Non- redeemable Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2023   198.6      
Beginning balance at Dec. 31, 2023 $ (742) $ 6,946 $ (3,399) $ (4,373) $ 84
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,093   1,071   22
Shares issued - employee stock compensation plans (in shares)   0.8      
Shares issued - employee stock compensation plans (104) $ (104)      
Shares repurchased (in shares)   (0.8)      
Shares repurchased (250)   (250)    
Share-based compensation expense 130 $ 130      
Dividends to shareholders (122)   (122)    
Net change in fair value of financial instruments 75     75  
Net foreign currency translation adjustments (132)     (132)  
Net postretirement benefit obligation 26     26  
Purchases of subsidiary shares from nonredeemable noncontrolling interests (1) $ (1)      
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (1)       (1)
Ending balance (in shares) at Mar. 31, 2024   198.6      
Ending balance at Mar. 31, 2024 $ (28) $ 6,971 (2,700) (4,404) 105
Beginning balance (in shares) at Dec. 31, 2024 216.0 216.0      
Beginning balance at Dec. 31, 2024 $ 6,305 $ 13,175 (2,309) (4,745) 184
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income [1] 986   965   21
Net income 982        
Shares issued - employee stock compensation plans (in shares)   0.7      
Shares issued - employee stock compensation plans (111) $ (111)      
Shares repurchased (in shares)   (0.6)      
Shares repurchased (250)   (250)    
Share-based compensation expense 147 $ 147      
Dividends to shareholders (146)   (146)    
Net change in fair value of financial instruments 3     3  
Net foreign currency translation adjustments 239     239  
Net postretirement benefit obligation 47     47  
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (14)       (14)
Remeasurement of redemption value of redeemable noncontrolling interest $ (11)       (11)
Ending balance (in shares) at Mar. 31, 2025 216.1 216.1      
Ending balance at Mar. 31, 2025 $ 7,195 $ 13,200 $ (1,740) $ (4,456) $ 191
[1] The Company’s Net income totaled $982 million for the quarter ended March 31, 2025, which included $4 million of Net loss related to redeemable noncontrolling interests.